The global hip reconstruction devices market will likely grow $126.6 million per annum in revenues between 2017 and 2022, according to a Transparency Market Research report.
Here are six observations:
1. In 2016, the market was valued at $5.68 billion.
2. Primary cemented hip replacement devices dominate the market.
3. A growing number of patients as well as an increasing number of osteoarthritis and rheumatoid arthritis cases will spur market growth through 2022.
4. The costliness of hip reconstruction procedures and devices will hinder market growth.
5. North America leads the market, driven by the demand for minimally invasive procedures and existence of strong hip reconstruction device vendors.
6. United Orthopedic, Exactech, Corin, Braun Melsungen, DePuy Synthes and Stryker represent key market players.